Tag: HoneyNaps
HoneyNaps is official in US
October 8, 2024HME News Staff
BOSTON – HoneyNaps, which is based in South Korea, has delivered its artificial intelligence sleep disorder diagnostic software SOMNUM to two medical institutions in the United States, it announced Oct. 7. "The U.S. is the largest sleep medicine market in the world and still holds significant growth potential,” a company representative said. “As we officially enter the U.S. market, we will solidify our business strategy to achieve a 10% market share within three years."...
In brief: HoneyNaps funding, Philips BiPAP update, F&P Healthcare results
May 29, 2024HME News Staff
BOSTON – HoneyNaps, an AI sleep data analysis company based in South Korea, has closed its series B round of funding, securing $11.6 million.
This funding is nearly three times the $3.9 million raised through series A funding back in 2021.
"This successful funding amidst a challenging investment climate has validated our position as Korea's leading sleep-tech company,” the company’s CFO stated in a press release. "These resources will enable us to...
HoneyNaps hits $16.2 million in funding
May 29, 2024HME News Staff
BOSTON – HoneyNaps, an AI sleep data analysis company based in South Korea, has closed its series B round of funding, securing $11.6 million.
This funding is nearly three times the $3.9 million raised through series A funding back in 2021.
"This successful funding amidst a challenging investment climate has validated our position as Korea's leading sleep-tech company,” the company’s CFO stated in a press release. "These resources will enable us to...